The evolving development landscape of biotherapeutics and their growing complexity from
simple antibodies into bi-and multi-specific molecules necessitates sophisticated discovery …

Subcutaneous (SC) administration is transforming the delivery of biopharmaceuticals,
facilitating care in a variety of healthcare settings, including home self-treatment. Large …

Abstract Background and Objectives Envafolimab is the first and only globally approved
subcutaneously injectable PD-L1 antibody for the treatment of instability-high (MSI-H) or …

Biopharmaceutical drugs, including proteins, peptides, and antibodies, are renowned for
their high specificity and efficacy, fundamentally transforming disease treatment paradigms …

Therapeutic monoclonal antibody (mAb) drug products are increasingly used to treat both
chronic and acute diseases. These mAb drug products are often developed for …

Excipients are ingredients in pharmaceutical products other than the active ingredient,
added to facilitate manufacturing, enhance stability or modulate release and bioavailability …

Hyaluronidases have been a subject of great interest in medical and cosmeceutical
applications. Previously, our group demonstrated that the venom glands of Vespa tropica …

Freeze drying is one of the common methods to extend the long-term stability of biologicals.
Biological products in solid form have the advantages of convenient transportation and …

Objective Existing healthcare systems face finite resource allocation and budgetary
constraints, resulting in a substantial need for innovative solutions to enhance service …

This article explores the significant improvements in manufacturing of monoclonal
antibodies (mAbs) and antibody-drug conjugates (ADCs) enabled by the microgravity …